Home
Why Choose Fox Chase?
Patient Center
Learn About Cancer
Find a Doctor
Cancer Genome Institute
Prevention, Risk and Screening
 
Research at Fox Chase
Research Areas
Faculty
Research Facilities
Technology Transfer
Awards and Honors for Research
Postdoctoral Research Program
Graduate Student Programs
Pre-Graduate Research Programs
Talbot Research Library
Partner Hospitals
For Health Professionals
Giving and Volunteering
Temple Health
Temple University School of Medicine
Temple University

American Russian Cancer Alliance (ARCA)

ARCA Publications

Matthew Robinson, PhD

Publications
  • Reddy S, Shaller CC, Doss M, Shchaveleva I, Marks JD, Yu JQ, Robinson MK. Evaluation of the anti-HER2 C6.5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Clin Cancer Res. 17:1509-1520, 2011. PMID:21177408.
  • Reddy S, Robinson MK. Immuno-Positron Emission Tomography in Cancer Models. Semin Nucl Med. 2010 May 40:182-189. 2010 PMID: 20350627.
  • Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, Gonzalez Trotter DE, Adams GP. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res. 2005 Feb 15;65(4):1471-8.
Posters
ARCA
Click for PDF of Poster
  • Reddy, S., Shaller, C., Doss, M., Shchaveleva, I. , Akulinichev, S.V., Yu, J.Q., Robinson, M.K. Preclinical evaluation of an anti-HER2 diabody to image response to trastuzumab therapy, IBC's 20th International Conference on Antibody Engineering, San Diego, CA, 2009.

Gregory Adams, PhD

Publications
  • Yuan QA, Robinson MK, Simmons HH, Russeva M, Adams GP. Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning. Cancer Immunol Immunother. 2008;14:875-82.
  • Yuan QA, Simmons HH, Robinson MK, Russeva M, Marasco WA, Adams GP. Development of engineered antibodies specific for the mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer. Mol. Cancer Ther. 2006;5:2096-2105.
  • Robinson MK, Doss M, Shaller C, Narayanan D, Marks JD, Adler LP, Gonzalez Trotter DE, Adams GP. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res. 2005 Feb 15;65(4):1471-8.
  • Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner. González Trotter DE, Manjeshwar RM, Doss M, Shaller C, Robinson MK, Tandon R, Adams GP, Adler LP. J Nucl Med. 2004 Jul;45(7):1237-44.

Robert Schnoll, PhD

Publications
  • Schnoll, RA Engstrom, PF Subramanian, S Demidov, L Wielt, DB Prevalence and correlates of tobacco among Russian cancer patients: implications for the development of smoking cessation interventions at a cancer center in Russia. Int J Behav Med. 2006;13(1):16-25.
  • Schnoll, RA Engstrom, PF Subramanian, S Demidov, L Wielt, DB. Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation. Int J Behav Med. 2006;13(1): 8-15.
  • Schnoll, RA Subramanian, S. Martinez, E. Engstrom, PF. Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients. Int J Behv Med. 2010 Nov 14(Epub ahead of print).